ADAMTS13 and myeloproliferative disorder: In our study, we aimed to evaluate the possible role of markers of endothelial damage, such as ADAMTS13, platelet-derived microvesicles (MVs), von Willebrand factor (VWF), and Factor VIII activity (FVIII:C), in the pathogenesis of SVT in MPN patients.